Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
Publisher
Aptose Biosciences
Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.
Canonical metadata stays public, while full text remains on the original site.